59 research outputs found
Clinical predictors of transvenous biphasic defibrillation thresholds.
Transvenous lead systems have become routine for defibrillator placement. However, previous studies of clinical predictors of an adequate nonthoracotomy defibrillation threshold (DFT) evaluated monophasic waveforms or more complex lead systems, including subcutaneous patches. Accordingly, this study is a prospective evaluation of the predictors of an adequate biphasic DFT in 114 consecutive patients undergoing cardioverter-defibrillator implantation with a single transvenous lead. For each subject, 38 parameters were assessed, including standard demographic, electrocardiographic, echocardiographic, and radiographic measurements. An adequate DFT (\u3c or =20 J) was achieved in 92% of patients. Multivariable analysis revealed 2 independent factors predictive of a high threshold: echocardiographic measurements of left ventricular dilation (odds ratio = 0.16, 95% confidence interval 0.05 to 0.53, p = 0.003) and body size (odds ratio = 0.36, 95% confidence interval 0.17 to 0.73; p = 0.005). No patient with a normal left ventricular end-diastolic dimension had a high DFT, whereas 14% (9 of 66) of those with left ventricular dilation had elevated thresholds. When the DFT cutoff was lowered to 15 J, as is necessary with some downsized pulse generators, an adequate threshold was observed in 84% of patients and the same 2 independent predictors of high thresholds were found. These results indicate that an adequate transvenous DFT can be predicted from simple clinical parameters
Chronic rise in monophasic defibrillation thresholds with a transvenous lead system.
This study was a prospective evaluation of chronic changes of defibrillation thresholds in 31 clinically stable patients with a single transvenous lead, optimal shock polarity, and uniform testing protocol. At a mean follow-up of 273 +/- 146 days, defibrillation thresholds increased 26%, from 13.2 +/- 5.6 J to 17.1 +/- 6:0 J (p \u3c 0.001), and shock impedance increased from 46.2 +/- 7.0 omega to 51.2 +/- 6.2 omega (p \u3c 0.001)
Exciton self-trapping in bulk polyethylene
We studied the behaviour of an injected electron\u2013hole pair in crystalline polyethylene theoretically. Time-dependent adiabatic evolution by ab initio molecular dynamics simulations show that the pair will become self-trapped in the perfect crystal, with a trapping energy of about 0.38 eV, with formation of a pair of trans-gauche conformational defects, three C2H4 units apart on the same chain. The electron is confined in the interchain pocket created by a local, 120\u25e6 rotation of the chain between the two defects, while the hole resides on the chain and is much less bound. Despite the large energy stored in the trapped excitation, there does not appear to be a direct non-radiative channel for electron\u2013hole recombination. This suggests that intrinsic self-trapping of electron\u2013hole pairs inside the ideal quasi-crystalline fraction of polyethylene might not be directly relevant for electrical damage in high-voltage cables
Clinical predictors of transvenous defibrillation energy requirements.
Nonthoracotomy and, more recently, transvenous lead systems have become routine for initial implantable cardioverter-defibrillator (ICD) placement. Previous studies of clinical predictors of nonthoracotomy defibrillation energy requirements evaluated multiple complex lead systems that included subcutaneous patches. However, the predictors of an adequate transvenous defibrillation threshold (DFT) have not been assessed previously. Accordingly, the present study is a prospective evaluation of DFT using a uniform testing protocol in 119 consecutive patients undergoing ICD implantation with a single transvenous lead. For each patient, 38 parameters were assessed including standard clinical, echocardiographic, and radiographic measures. An adequate monophasic DFT (\u3c or =20 J) was achieved in 76% of patients. Multivariable analysis revealed 3 independent factors predictive of a high threshold: preoperative amiodarone use (odds ratio = 5.8, p \u3c or =0.002), echocardiographic measures of left ventricular dilation (odds ratio = 0.47, p \u3c or =0.005) and body size (odds ratio = 0.51, p \u3c or =0.006). Patients receiving amiodarone who also had left ventricular dilation constitute a group at considerable (69%) risk for having a high DFT. In contrast, patients with neither of these risk factors have only an 11% chance of having a high threshold. We conclude that an adequate transvenous DFT can be predicted from simple clinical parameters
Intravenous amiodarone suppression of electrical storm refractory to chronic oral amiodarone.
We report the case of an electrical storm in a cardiac arrest survivor with an ICD, in whom chronic oral amiodarone failed to suppress ventricular arrhythmias, and in whom intravenous amiodarone resulted in stability for 6 weeks prior to successful cardiac transplantation. Intravenous amiodarone can be successful in suppressing life-threatening ventricular arrhythmias, even when chronic oral amiodarone is unsuccessful
- …